Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Posch

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 31, 2025
A patient with blue-gray pigmentation of the skinSophie Burner, Astrid M Fink, Friedrich Breier, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 28, 2020
Georg Stary, Christian Posch, Peter Wolf, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 10, 2011
Perianal ulcer - amebiasis cutisChristian Posch, Julia Walochnik, Biljana Schuller-Lukic, et al.
Cancers|March 28, 2024
T-Cell Subtypes and Immune Signatures in Cutaneous Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor TherapyMagdalena Absmaier-Kijak, Caterina Iuliano, Susanne Kaesler, et al.
Dermatology and Therapy|April 9, 2026
Addictions in Hidradenitis Suppurativa: A Cross-Sectional Pilot StudyAlexander Böhner, Wanja Steinhauser, Rosi Wang, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 28, 2017
Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in AustriaLeo Richter, Igor Vujic, Alma Sesti, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 3, 2017
Etanercept, Adalimumab und Ustekinumab bei Psoriasis: Analyse von 209 Behandlungsreihen in ÖsterreichLeo Richter, Igor Vujic, Alma Sesti, et al.
Oncotarget|November 9, 2018
MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomasChristian Posch, Martina Sanlorenzo, Jeffrey Ma, et al.
JAMA Dermatology|December 18, 2014
The risk of melanoma in pilots and cabin crew: UV measurements in flying airplanesMartina Sanlorenzo, Igor Vujic, Christian Posch, et al.
The Journal of Investigative Dermatology|May 11, 2016
Searching for the Chokehold of NRAS Mutant MelanomaChristian Posch, Igor Vujic, Babak Monshi, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 31, 2025
A patient with blue-gray pigmentation of the skinSophie Burner, Astrid M Fink, Friedrich Breier, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 28, 2020
Georg Stary, Christian Posch, Peter Wolf, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 10, 2011
Perianal ulcer - amebiasis cutisChristian Posch, Julia Walochnik, Biljana Schuller-Lukic, et al.
Cancers|March 28, 2024
T-Cell Subtypes and Immune Signatures in Cutaneous Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor TherapyMagdalena Absmaier-Kijak, Caterina Iuliano, Susanne Kaesler, et al.
Dermatology and Therapy|April 9, 2026
Addictions in Hidradenitis Suppurativa: A Cross-Sectional Pilot StudyAlexander Böhner, Wanja Steinhauser, Rosi Wang, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 28, 2017
Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in AustriaLeo Richter, Igor Vujic, Alma Sesti, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 3, 2017
Etanercept, Adalimumab und Ustekinumab bei Psoriasis: Analyse von 209 Behandlungsreihen in ÖsterreichLeo Richter, Igor Vujic, Alma Sesti, et al.
Oncotarget|November 9, 2018
MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomasChristian Posch, Martina Sanlorenzo, Jeffrey Ma, et al.
JAMA Dermatology|December 18, 2014
The risk of melanoma in pilots and cabin crew: UV measurements in flying airplanesMartina Sanlorenzo, Igor Vujic, Christian Posch, et al.
The Journal of Investigative Dermatology|May 11, 2016
Searching for the Chokehold of NRAS Mutant MelanomaChristian Posch, Igor Vujic, Babak Monshi, et al.
Pageof 10